Amniotic Membrane Market Demand & Analysis | Report 2028

The amniotic membrane market is expected to reach US$ 2,808.39 million by 2028 from US$ 1,827.85 million in 2022, growing at a CAGR of 7.4% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the rising use of amniotic membranes in eye surgeries. However, the breakdown of membranes is hindering the growth of the global amniotic membrane market

North America held the largest market for amniotic membrane, with the US holding the largest share of the regional market, followed by Canada and Mexico. The US held the largest share in 2019 and is expected to follow a similar trend during the forecast period. According to the American academy of Ophthalmology, there were 718 thousand surgeries that occurred yearly in 2020 in the US. According to the American academy of Ophthalmology, glaucoma affected more than 2.7 million Americans aged 40 and above in 2020. Amniotic membrane is widely used in eye surgery as a biological bandage to heal the damaged eye tissue. It is thin, lightweight, elastic and almost transparent in nature making it suitable for use on the surface of the eye. It can be sutured or glued into place with tissue glue. Amniotic membrane is used to treat chemical burns, ulcers of the cornea or conjunctiva, diseases causing devastating ulcerations and during surgical procedures where eye tissue has to be excised. For instance, amniotic membrane is used successfully in Pterygium surgery procedure which is commonly performed in both developed and developing economies. Pterygium is a benign growth on the conjunctiva of the eye, usually in the area closest to the nose. These growths can cause irritation in the eye and need to be removed surgically. The deficit left after the removal is successfully healed with amniotic membrane placements. Some other applications wherein amniotic membranes are used increasingly are ulcers, burns, wounds, and animal bites.

Strategic Insights

Amniotic membrane therapy is an option for those who are at risk of limb amputation. An amniotic membrane is a sustainable and powerful option, especially with new preservation techniques that allow them to be available across various clinical settings such as hospitals, clinics, specialty clinics, and ambulatory surgical centers.

Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products, Inc.; Amnio technology, LLC.; and Surgenex, LLC   are among the leading companies in the global amniotic membrane market. The market is anticipated to flourish with the development of new innovative products by market players.

• In November 2022, it has been reported by the Journal of Biomaterials Applications that human amniotic membrane or amnion can resolve some bottlenecks in the regenerative medicine issues such as tissue engineering and cell therapy. In the recent past, biomedical applications of amnion have evolved from a simple sheet for skin or cornea repair to high-technology applications such as amnion nanocomposite, powder, or hydrogel for the regeneration of cartilage, muscle, tendon, and heart. Thus, new applications of amnion in research and clinical applications, from regenerative medicine to cancer therapy is expected to aid the overall amniotic membrane market growth during the forecast period.
• In August 2022, CryoTek CAM launched Amniograft, the only graft used for eye transplant application. Amniograft’s cryopreservation method maintains all the biological components of the tissue, such as heavy chain hyaluronic acid (HCHA) and pentraxin 3 (PTX3), which help to rapidly restore the healing capabilities of the ocular surface. The product is widely used for conjunctivochalase (CCH)also known as mechanical dry eye (MDE)

Lucrative Regions for Amniotic Membrane Market

Get more information on this report : Request Free Sample PDF

Based on enzyme, the global amniotic membrane market is divided intocryopreserved amniotic membrane and dehydrated amniotic membrane. Cropreserved amniotic membrane segment captured the largest share in 2019 and is expected to continue a similar trend during the forecast period. Cryopreservation was first introduced by Lee and Tseng and has been proven to achieve high success rate in amniotic membrane transplantation and has been distinguished from many other types of methods for its advantages such as prolonging use span, optimally retaining tissue structure, and minimizing infection risk. On the other hand, dehydrated amniotic membrane is expected to witness the highest growth during the forecast period owing to its increasing shelf-life.

Application Insights

Based on application, the amniotic membrane market has been segmented into surgical wounds, ophthalmology, and others. The surgical wounds captured the largest share in 2019 and is expected to continue a similar trend during the forecast period. Owing to the presence of large number of cytokines and essential growth factors, amniotic membrane is an ideal option for treating surgical wounds. The also enhances the wound healing process.

End User Insights

Based on end user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic & research institutes. In 2019, the hospitals segment held the largest share of amniotic membrane market and is expected to continue a similar trend during the forecast period. The adoption of new technology methods by hospitals across the globe has resulted in the growth of overall industry. Amniotic membrane therapy is an option for those who are at risk of limb amputation. An amniotic membrane is a sustainable and powerful option, especially with new preservation techniques that allow them to be available across various clinical settings such as hospitals, clinics, specialty clinics, and ambulatory surgical centers.

Companies operating in the amniotic membrane market are adopting the product innovation strategy to meet the evolving customer demands worldwide, allowing them to maintain their brand name in the global amniotic membrane market.

The report segments the amniotic membrane market as follows:

The amniotic membrane market is bifurcated into enzyme, application, end user, and geography. Based on enzyme, the global amniotic membrane market is divided intocryopreserved amniotic membrane and dehydrated amniotic membrane. Based on application, the amniotic membrane market has been segmented into surgical wounds, ophthalmology, and others. Based on end user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic & research institutes.  Based on geography, the amniotic membrane market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).